Stephan Targan

4.5k citations

45 papers · 3.1k indexed · 1 hit paper · h-index 16

Impact in

Genetics top 0.5%
- Inflammatory Bowel Disease
Epidemiology top 2%
- Microscopic Colitis
- Autoimmune and Inflammatory Disorders

Papers in

Immunology 21
- Immunodeficiency and Autoimmune Disorders 8
- Immune Cell Function and Interaction 8
- T-cell and B-cell Immunology 4
Genetics 25
- Inflammatory Bowel Disease 25

Co-authors: Bruce E. Sands Paul Rutgeerts Kimberly L. DeWoody T Schaible Sander J. H. van Deventer Stephen B. Hanauer Daniel H. Present Daniel K. Podolsky
Journals: Gastroenterology (15 papers)The American Journal of Gastroenterology (6 papers)Inflammatory Bowel Diseases (4 papers)Frontiers in Immunology (3 papers)Cellular Immunology (3 papers)
Partner nations: United States Canada Belgium

In The Last Decade

Stephan Targan

42 papers receiving 2.9k citations

Hit Papers

align trajectories log scale

Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease 1999 · 2.0k citations

Peers

Countries citing papers authored by Stephan Targan

Since Specialization

Citations

This map shows the geographic impact of Stephan Targan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephan Targan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephan Targan more than expected).

Fields of papers citing papers by Stephan Targan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephan Targan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephan Targan. The network helps show where Stephan Targan may publish in the future.

Co-authors

The 25 scholars most cited alongside Stephan Targan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Stephan Targan Line = papers co-authored together Stephan Targan links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	TL1A: A model for a precision medicine approach in the treatment of Crohn’s disease and ulcerative colitis Advances in pharmacology ·Janine Bilsborough, Stephan Targan	2024	0
2	Toll-like receptor 7 protects against intestinal inflammation and restricts the development of colonic tissue-resident memory CD8+ T cells Frontiers in Immunology ·Jang-Pyo Hong, Masato Tsuda, Naoki Oshima, J. Nutsch, Michelle Wong, ROBERT MACMILLAN, Lisa Thomas, Brenda Salumbides, 조광수, Christopher E. Hardy, Deepti Dhall, Stephan Targan, Kathrin S. Michelsen	2024	1
3	31 A CLINICAL SCORE FOR UC2CD, A NOVEL SUBGROUP IN INFLAMMATORY BOWEL DISEASES (IBD) WITH DISTINCT SEROLOGICAL, GENETIC AND CLINICAL FEATURES Gastroenterology ·Tullia Blackburn, Carol J. Landers, Shaohong Yang, Stephan Targan, Dermot McGovern	2024	0
4	Phase 2 Trial of Anti-TL1A Monoclonal Antibody Tulisokibart for Ulcerative Colitis New England Journal of Medicine ·Bruce E. Sands, Brian G. Feagan, Laurent Peyrin‐Biroulet, Silvio Danese, David T. Rubin, Olivier Laurent, Allison Luo, Deanna D. Nguyen, Jiandong Lu, Rebecca O. M. Cowie, Jarosław Leszczyszyn, Radosław Kempiński, Dermot McGovern, Christopher Ma, Timothy E. Ritter, Stephan Targan	2024	23
5	BATF3 Protects Against Metabolic Syndrome and Maintains Intestinal Epithelial Homeostasis Frontiers in Immunology ·Jang-Pyo Hong, ROBERT MACMILLAN, J. Nutsch, Shyam K. More, Lisa Thomas, Seila Panizzolo, 洪世謙, Susan Irvine, Brenda Salumbides, Yosuke Shimodaira, Helen S. Goodridge, Stephan Targan, Kathrin S. Michelsen	2022	6
6	Diagnostic and therapeutic potential of RNASET2 in Crohn’s disease: Disease-risk polymorphism modulates allelic-imbalance in expression and circulating protein levels and recombinant-RNASET2 attenuates pro-inflammatory cytokine secretion Frontiers in Immunology ·J V NIMMO, Anujin Bat-Amgalan, Simon G. Coetzee, Dermot McGovern, Dennis J. Hazelett, Stephan Targan, Rivkah Gonsky	2022	4
7	Combination Therapy With Immunomodulators Improves the Pharmacokinetics of Infliximab But Not Vedolizumab or Ustekinumab Clinical Gastroenterology and Hepatology ·Andrés Yarur, Dermot McGovern, María T. Abreu, Adam S. Cheifetz, T. V. S. Sarma, Parakkal Deepak, Jim Mann, Poonam Beniwal‐Patel, Marla Dubinsky, Stephan Targan, Gil Melmed	2022	17
8	Sa1585: CLINICAL, RADIOGRAPHIC, SEROLOGIC, AND GENETIC ASSOCIATIONS WITH HEPATIC STEATOSIS SEVERITY AND NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES (IBD) Gastroenterology ·Phillip Gu, Shishir Dube, 幹夫原, Dalin Li, Talin Haritunians, Eric Vasiliauskas, Christina Ha, Gaurav Syal, Nirupama Bonthala, Shaohong Yang, Phillip Fleshner, Gil Melmed, Mazen Noureddin, Cindy Kallman, Stephan Targan, Dermot McGovern	2022	1
9	Association of Ribonuclease T2 Gene Polymorphisms With Decreased Expression and Clinical Characteristics of Severity in Crohn’s Disease Gastroenterology ·Rivkah Gonsky, Phillip Fleshner, Richard L. Deem, J V NIMMO, Dalin Li, Alka A. Potdar, Janine Bilsborough, Shaohong Yang, Dermot McGovern, Stephan Targan	2017	20
10	The Impact of Preoperative Serum Anti-TNFα Therapy Levels on Early Postoperative Outcomes in Inflammatory Bowel Disease Surgery Annals of Surgery ·C. H. Lim, Marla Dubinsky, Gil Melmed, Eric Vasiliauskas, Dror Berel, Dermot McGovern, Andrew Ippoliti, David Q. Shih, Stephan Targan, Phillip Fleshner	2014	132
11	Does Preoperative Immunosuppression Influence Unplanned Hospital Readmission After Surgery in Patients With Crohn’s Disease? Diseases of the Colon & Rectum ·E.C. White, Gil Melmed, Eric Vasiliauskas, Marla Dubinsky, Andrew Ippoliti, Dermot McGovern, Stephan Targan, Phillip Fleshner	2012	16
12	A genome-wide search identifies potential new susceptibility loci for Crohn's disease Inflammatory Bowel Diseases ·Yuanhong Ma, Jeffrey D. Ohmen, Zhiming Li, L. Gordon Bentley, Colleen McElree, Sheila Pressman, Stephan Targan, Nathan Fischel‐Ghodsian, Jerome I. Rotter, Hui Ying Yang	2007	10
13	CD2 mediates activation of the IFN‐γ intronic STAT binding region in mucosal T cells European Journal of Immunology ·Rivkah Gonsky, Richard L. Deem, Howard A. Young, Stephan Targan	2003	15
14	Identification of a novel bacterial sequence associated with Crohn's disease Gastroenterology ·Christopher L. Sutton, Jeong Hun Kim, D. Marlow, Jim Myka Z., Bo Wei, Carol J. Landers, Stephan Targan, Jonathan Braun	2000	172
15	Identification of A Prodromal Period in Crohn's Disease But Not Ulcerative Colitis The American Journal of Gastroenterology ·Alessandro Lucas Da Silva, Angelos Tsatsis, Evelyn J. Chow, Siamak Tabibzadeh, A. L. Smith, Stephan Targan, 義弘福本	2000	100
16	Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease New England Journal of Medicine ·Daniel H. Present, Paul Rutgeerts, Stephan Targan, Stephen B. Hanauer, Lloyd Mayer, R. A. van Hogezand, Daniel K. Podolsky, Bruce E. Sands, 宏柴田, Kimberly L. DeWoody, T Schaible, Sander J. H. van Deventer Hit paper breakdown →	1999	1984
17	ANTI-TUMOR NECROSIS FACTOR-α THERAPY IN CROHNʼS DISEASE: A MAGIC BULLET FINALLY HITS ITS MARK Inflammatory Bowel Diseases ·Scott E. Plevy, Stephan Targan	1996	2
18	Ulcerative colitis-linked antineutrophil cytoplasmic antibody in the cotton-top tamarin model of colitis Gastroenterology ·Stephan Targan, Carol J. Landers, Norval W. King, JD Nielsen, Fergus Shanahan	1992	15
19	Role of the CD45 (T-200) molecule in anti-CD3-triggered T cell-mediated cytotoxicity Cellular Immunology ·Richard L. Deem, Fergus Shanahan, 亮介長田, Stephan Targan	1988	4
20	Hermansky-Pudlak syndrome: an immunologic assessment of 15 cases The American Journal of Medicine ·Fergus Shanahan, Linda M. Randolph, Richard A. King, Ronald S. Oseas, Zhoucong Xu, Carl J. Witkop, Jerome I. Rotter, Stephan Targan	1988	22

About Stephan Targan

Stephan Targan is a scholar working on Immunology, Genetics, Epidemiology, Hepatology and Gastroenterology, having authored 45 papers that have together received 3.1k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (25 papers), Microscopic Colitis (14 papers), Immunodeficiency and Autoimmune Disorders (8 papers), Immune Cell Function and Interaction (8 papers), Eosinophilic Esophagitis (7 papers), T-cell and B-cell Immunology (4 papers), Helicobacter pylori-related gastroenterology studies (3 papers) and Acute Lymphoblastic Leukemia research (3 papers). The work is most often cited by research in Genetics (2.1k citations), Epidemiology (1.5k citations), Gastroenterology (206 citations), Immunology (710 citations) and Surgery (1.0k citations). Stephan Targan has collaborated with scholars based in United States, Canada and Belgium. Frequent co-authors include Bruce E. Sands, Paul Rutgeerts, Kimberly L. DeWoody, T Schaible, Sander J. H. van Deventer, Stephen B. Hanauer, Daniel H. Present, Daniel K. Podolsky, R. A. van Hogezand and Lloyd Mayer. Their work appears in journals such as Gastroenterology, The American Journal of Gastroenterology, Inflammatory Bowel Diseases, Frontiers in Immunology and Cellular Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact